Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases

Details for Australian Patent Application No. 2004243500 (hide)

Owner Schering Aktiengesellschaft

Inventors Fuhrmann, Ulrike; Siemeister, Gerhard; Schneider, Martin; Hoffmann, Jens

Agent Davies Collison Cave

Pub. Number AU-A-2004243500

PCT Pub. Number WO2004/105768

Priority 10/446,165 27.05.03 US

Filing date 27 May 2004

Wipo publication date 9 December 2004

International Classifications

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/105768 Priority application(s): WO2004/105768

23 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243503-Implants comprising functionalized carbon surfaces

2004243492-Hydrazone derivatives for combatting harmful insects and arachnids